These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11201098)

  • 1. Role of corticostriatal and nigrostriatal inputs in malonate-induced striatal toxicity.
    Meldrum A; Dunnett SB; Everitt BJ
    Neuroreport; 2001 Jan; 12(1):89-93. PubMed ID: 11201098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo vulnerability of dopamine neurons to inhibition of energy metabolism.
    Zeevalk GD; Manzino L; Hoppe J; Sonsalla P
    Eur J Pharmacol; 1997 Feb; 320(2-3):111-9. PubMed ID: 9059843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosinergic protection of dopaminergic and GABAergic neurons against mitochondrial inhibition through receptors located in the substantia nigra and striatum, respectively.
    Alfinito PD; Wang SP; Manzino L; Rijhsinghani S; Zeevalk GD; Sonsalla PK
    J Neurosci; 2003 Nov; 23(34):10982-7. PubMed ID: 14645494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The corticostriatal system mediates the "paradoxical" contraversive rotation but not the striatal hyperexpression of Fos induced by amphetamine early after 6-hydroxydopamine lesion of the nigrostriatal pathway.
    Lopez-Martin E; Rozas G; Rodriguez J; Guerra MJ; Labandeira-Garcia JL
    Exp Brain Res; 1998 May; 120(2):153-63. PubMed ID: 9629957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NMDA receptors modulate dopamine loss due to energy impairment in the substantia nigra but not striatum.
    Zeevalk GD; Manzino L; Sonsalla PK
    Exp Neurol; 2000 Feb; 161(2):638-46. PubMed ID: 10686083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Striatal glutamate release evoked in vivo by NMDA is dependent upon ongoing neuronal activity in the substantia nigra, endogenous striatal substance P and dopamine.
    Marti M; Manzalini M; Fantin M; Bianchi C; Della Corte L; Morari M
    J Neurochem; 2005 Apr; 93(1):195-205. PubMed ID: 15773919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Striatal, pallidal, and pars reticulata evoked inhibition of nigrostriatal dopaminergic neurons is mediated by GABA(A) receptors in vivo.
    Paladini CA; Celada P; Tepper JM
    Neuroscience; 1999 Mar; 89(3):799-812. PubMed ID: 10199614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malonate-induced generation of reactive oxygen species in rat striatum depends on dopamine release but not on NMDA receptor activation.
    Ferger B; Eberhardt O; Teismann P; de Groote C; Schulz JB
    J Neurochem; 1999 Sep; 73(3):1329-32. PubMed ID: 10461928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of prelimbic and sensorimotor cortices on striatal neurons in the rat: electrophysiological evidence for converging inputs and the effects of 6-OHDA-induced degeneration of the substantia nigra.
    Florio T; Di Loreto S; Cerrito F; Scarnati E
    Brain Res; 1993 Aug; 619(1-2):180-8. PubMed ID: 8374776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of nigrostriatal dopamine depletion on the thalamic parafascicular nucleus.
    Kusnoor SV; Bubser M; Deutch AY
    Brain Res; 2012 Mar; 1446():46-55. PubMed ID: 22353754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Afferent influences on striatal development in organotypic cocultures.
    Snyder-Keller A; Tseng KY; Lyng GD; Graber DJ; O'Donnell P
    Synapse; 2008 Jul; 62(7):487-500. PubMed ID: 18435420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortical regulation of striatal medium spiny neuron dendritic remodeling in parkinsonism: modulation of glutamate release reverses dopamine depletion-induced dendritic spine loss.
    Garcia BG; Neely MD; Deutch AY
    Cereb Cortex; 2010 Oct; 20(10):2423-32. PubMed ID: 20118184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose- and sex-dependent effects of the neurotoxin 6-hydroxydopamine on the nigrostriatal dopaminergic pathway of adult rats: differential actions of estrogen in males and females.
    Murray HE; Pillai AV; McArthur SR; Razvi N; Datla KP; Dexter DT; Gillies GE
    Neuroscience; 2003; 116(1):213-22. PubMed ID: 12535954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Divergent regulatory mechanisms governing BDNF mRNA expression in cerebral cortex and substantia nigra in response to striatal target ablation.
    Rite I; Machado A; Cano J; Venero JL
    Exp Neurol; 2005 Mar; 192(1):142-55. PubMed ID: 15698628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin-immunoreactive neurons in the rat striatum: effects of corticostriatal and nigrostriatal dopaminergic lesions.
    Salin P; Kerkerian-Le Goff L; Heidet V; Epelbaum J; Nieoullon A
    Brain Res; 1990 Jun; 521(1-2):23-32. PubMed ID: 1976412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 6-Hydroxydopamine injections into the nigrostriatal pathway attenuate striatal malonate and 3-nitropropionic acid lesions.
    Maragos WF; Jakel RJ; Pang Z; Geddes JW
    Exp Neurol; 1998 Dec; 154(2):637-44. PubMed ID: 9878198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apomorphine-induced alterations in striatal and substantia nigra pars reticulata glutamate following unilateral loss of striatal dopamine.
    Touchon JC; Holmer HK; Moore C; McKee BL; Frederickson J; Meshul CK
    Exp Neurol; 2005 May; 193(1):131-40. PubMed ID: 15817272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The vulnerability of striatal projection neurons and interneurons to excitotoxicity is differentially regulated by dopamine during development.
    Pezzi S; Checa N; Alberch J
    Int J Dev Neurosci; 2005 Jun; 23(4):343-9. PubMed ID: 15927758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Respective contributions of neuronal activity and presynaptic mechanisms in the control of the in vivo release of dopamine.
    Chéramy A; Barbeito L; Godeheu G; Desce JM; Pittaluga A; Galli T; Artaud F; Glowinski J
    J Neural Transm Suppl; 1990; 29():183-93. PubMed ID: 1972733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subtype selective antagonism of substantia nigra pars compacta Group I metabotropic glutamate receptors protects the nigrostriatal system against 6-hydroxydopamine toxicity in vivo.
    Vernon AC; Zbarsky V; Datla KP; Croucher MJ; Dexter DT
    J Neurochem; 2007 Nov; 103(3):1075-91. PubMed ID: 17714448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.